28.55
price up icon2.44%   0.68
pre-market  시장 영업 전:  29.37   0.82   +2.87%
loading
전일 마감가:
$27.87
열려 있는:
$27.97
하루 거래량:
143.58K
Relative Volume:
0.40
시가총액:
$1.87B
수익:
$282.04M
순이익/손실:
$221.88M
주가수익비율:
8.4824
EPS:
3.3658
순현금흐름:
$-449.57M
1주 성능:
+3.03%
1개월 성능:
-2.23%
6개월 성능:
+2.35%
1년 성능:
+12.67%
1일 변동 폭
Value
$27.96
$28.70
1주일 범위
Value
$27.75
$28.70
52주 변동 폭
Value
$22.36
$31.23

갈라파고스 ADR Stock (GLPG) Company Profile

Name
명칭
Galapagos Nv Adr
Name
전화
-
Name
주소
-
Name
직원
704
Name
트위터
@GalapagosGlobal
Name
다음 수익 날짜
2024-10-30
Name
최신 SEC 제출 서류
Name
GLPG's Discussions on Twitter

GLPG을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
GLPG
Galapagos Nv Adr
28.55 1.87B 282.04M 221.88M -449.57M 3.3658
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

갈라파고스 ADR Stock (GLPG) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-02-14 다운그레이드 Morgan Stanley Equal-Weight → Underweight
2024-11-20 다운그레이드 Kepler Hold → Reduce
2024-09-09 개시 Leerink Partners Market Perform
2024-08-02 다운그레이드 Raymond James Outperform → Mkt Perform
2024-03-28 다운그레이드 BofA Securities Neutral → Underperform
2024-03-07 재개 Morgan Stanley Equal-Weight
2023-08-24 다운그레이드 Citigroup Buy → Neutral
2023-05-05 업그레이드 Raymond James Mkt Perform → Outperform
2023-01-23 업그레이드 Jefferies Underperform → Hold
2022-11-07 다운그레이드 Raymond James Outperform → Mkt Perform
2022-09-09 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2022-01-27 업그레이드 Citigroup Neutral → Buy
2021-08-19 다운그레이드 Barclays Overweight → Equal Weight
2021-08-06 다운그레이드 Deutsche Bank Buy → Hold
2021-04-20 개시 Deutsche Bank Buy
2021-04-14 업그레이드 Barclays Equal Weight → Overweight
2021-02-23 업그레이드 BofA Securities Underperform → Neutral
2021-02-19 업그레이드 Raymond James Mkt Perform → Outperform
2021-02-11 다운그레이드 Citigroup Buy → Neutral
2021-01-19 업그레이드 Morgan Stanley Equal-Weight → Overweight
2020-11-19 개시 Maxim Group Buy
2020-10-21 다운그레이드 Goldman Neutral → Sell
2020-08-25 다운그레이드 Jefferies Buy → Hold
2020-08-24 다운그레이드 H.C. Wainwright Buy → Neutral
2020-08-19 다운그레이드 Barclays Overweight → Equal Weight
2020-08-19 업그레이드 Citigroup Neutral → Buy
2020-07-10 다운그레이드 Stifel Buy → Hold
2020-03-30 업그레이드 Jefferies Hold → Buy
2020-03-18 업그레이드 RBC Capital Mkts Underperform → Sector Perform
2020-02-25 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2020-02-24 다운그레이드 BofA/Merrill Neutral → Underperform
2020-02-20 다운그레이드 RBC Capital Mkts Sector Perform → Underperform
2020-01-06 다운그레이드 JP Morgan Overweight → Neutral
2019-12-18 다운그레이드 Citigroup Buy → Neutral
2019-12-17 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2019-12-13 다운그레이드 Credit Suisse Outperform → Neutral
2019-12-02 개시 BofA/Merrill Neutral
2019-09-09 재개 Morgan Stanley Overweight
2019-07-31 업그레이드 UBS Neutral → Buy
2019-07-29 다운그레이드 Jefferies Buy → Hold
모두보기

갈라파고스 ADR 주식(GLPG)의 최신 뉴스

pulisher
Jun 05, 2025

Planisware expands into Belgium to support the sustained growth of its business in the Benelux region - GlobeNewswire Inc.

Jun 05, 2025
pulisher
May 14, 2025

Galapagos stock holds as CEO change, spinoff plans halted By Investing.com - Investing.com India

May 14, 2025
pulisher
May 13, 2025

Galapagos stock holds as CEO change, spinoff plans halted - Investing.com

May 13, 2025
pulisher
May 08, 2025

Ratios in Focus: Analyzing Galapagos NV ADR (GLPG)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

May 08, 2025
pulisher
Apr 24, 2025

Galapagos stock holds Market Perform rating at Raymond James - Investing.com

Apr 24, 2025
pulisher
Jan 21, 2025

Galapagos To Spin Off Innovative Medicines Business - Forbes

Jan 21, 2025
pulisher
Jan 09, 2025

Belgium stocks higher at close of trade; BEL 20 up 0.06% - Investing.com

Jan 09, 2025
pulisher
Nov 20, 2024

Galapagos stock downgraded to Reduce on strategic concerns - Investing.com

Nov 20, 2024
pulisher
Nov 01, 2024

Galapagos stock outlook cautious with clinical readouts on the horizon, says Morgan Stanley - Investing.com

Nov 01, 2024
pulisher
Aug 26, 2024

Why This Rival To Gilead, Novartis Just Jumped 10% — And Why There Are Caveats - Investor's Business Daily

Aug 26, 2024
pulisher
Aug 23, 2024

Galapagos (GLPG) Up on FDA Nod to Begin Phase I/II Lymphoma Study - Yahoo Finance

Aug 23, 2024
pulisher
Mar 07, 2024

Morgan Stanley sets Galapagos stock at equalweight, $38 price target - Investing.com

Mar 07, 2024
pulisher
Dec 02, 2022

Billionaire hedge fund manager David Einhorn’s portfolio revealed - Daily Investor

Dec 02, 2022
pulisher
Jun 21, 2022

+ND Capital's European Investment Strategy Delivers Again as Sale of CellPoint to Galapagos Paves the Way for Disruptive Point-of-Care Cell Therapy Model for Cancer Patients - Barchart.com

Jun 21, 2022
pulisher
Jan 27, 2022

Galapagos Surges On New CEO and Upgrade News - Investing.com

Jan 27, 2022
pulisher
Aug 30, 2021

Galapagos NV announces retirement of CEO - Seeking Alpha

Aug 30, 2021
pulisher
Sep 28, 2020

Galapagos Gets First Commercial Drug With Jyseleca Approval - Yahoo Finance

Sep 28, 2020
pulisher
Aug 19, 2020

The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs - Benzinga

Aug 19, 2020
pulisher
Feb 11, 2020

The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology - Yahoo Finance

Feb 11, 2020
pulisher
Jun 08, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts - Yahoo Finance

Jun 08, 2019
pulisher
Apr 17, 2019

Galapagos NV (GLPG) Stock Price, Trades & News - GuruFocus.com

Apr 17, 2019
pulisher
Jul 27, 2018

AIM tech shares that broke America - Interactive Investor

Jul 27, 2018
pulisher
Jul 20, 2017

GLPG Stock Price and Chart — EURONEXT:GLPG - TradingView

Jul 20, 2017
pulisher
Dec 30, 2015

The 5 Best-Performing Non-S&P Stocks of 2015 - Forbes

Dec 30, 2015

갈라파고스 ADR (GLPG) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
자본화:     |  볼륨(24시간):